International Partnership for Microbicides
http://www.ipmglobal.org/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From International Partnership for Microbicides
EMA Says Yes To GSK’s Belantamab But Rejects Tagraxofusp & Emapalumab
GlaxoSmithKline's first-of-its kind treatment for multiple myeloma is among 11 new medicines that have won an EU approval nod from the European Medicines Agency this week.
GSK's Belantamab Among Drugs Seeking EU Approval Nod
GlaxoSmithKline's potential multiple myeloma treatment is one of several new products that could get an EU marketing thumbs up from the European Medicines Agency this week.
Moment Of Truth For Belantamab Mafodotin, Trikafta And Turalio At EMA
A number of drug companies are set to learn the fate of their marketing authorization applications in the EU this week.
GW Pharma's Cannabinoid Medicine Epidyolex Among CHMP Hopefuls
Seven new medicines, including GW Pharma's orphan cannabidiol product, Epidyolex, are due for an opinion from the European Medicines Agency this week on whether they should be recommended for pan-EU approval.
Company Information
- Industry
- Academic and Research Institutions